Commission Delegated Regulation (EU) 2022/1520 of 17 June 2022 amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Draft Joint Committee Decision (JCD) under consideration by the EU (EEAS) and the EFTA States (Iceland, Liechtenstein and Norway) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Legal documents
Commission Delegated Regulation (EU) 2022/1520 of 17 June 2022 amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Delegierte Verordnung (EU) 2022/1520 der Kommission vom 17. Juni 2022 zur Änderung der Verordnung (EU) Nr. 658/2014 des Europäischen Parlaments und des Rates hinsichtlich der Anpassung der Höhe der Gebühren, die der Europäischen Arzneimittel-Agentur für die Durchführung von Pharmakovigilanz-Tätigkeiten in Bezug auf Humanarzneimittel zu entrichten sind, an die Inflationsrate
History
30.08.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
17.06.2022
Adoption date in the EU
03.10.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.